The MYO1F, unconventional myosin type 1F, gene is fused to MLL in infant acute monocytic leukemia with a complex translocation involving chromosomes 7, 11, 19 and 22Tomohiko Taki, Yasuhide Hayashi, Masaharu Akiyama et al.|Oncogene|2005Cited by 43
High event‐free survival rate with minimum‐dose‐anthracycline treatment in childhood acute promyelocytic leukaemia: a nationwide prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study GroupHiroyuki Takahashi, Souichi Adachi, Tomoyuki Watanabe et al.|British Journal of Haematology|2016Cited by 21
JCCG ALL-B12: Evaluation of Intensified Therapies With Vincristine/Dexamethasone Pulses and Asparaginase and Augmented High-Dose Methotrexate for Pediatric B-ALLMotohiro Kato, Katsuyoshi Koh, Yasuhiro Okamoto et al.|Journal of Clinical Oncology|2024Cited by 16
High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemiaDaisuke Tomizawa, Souichi Adachi, Jun Matsubayashi et al.|Leukemia|2023Cited by 8
A Nationwide Clinical Trial ALL-B12: An Optimized Therapy for Pediatric B-Precursor Acute Lymphoblastic Leukemia with Excellent Overall Survival and Minimal Non-Relapse Mortality: A Report from the Japan Children's Cancer GroupMotohiro Kato, Katsuyoshi Koh, Yasuhiro Okamoto et al.|Blood|2023Cited by 3